课题基金 / 基金详情

Identification of SNPs on mature micro RNA to analyze origin of miRNA

Identification of SNPs on mature micro RNA to analyze origin of miRNA
鉴定成熟 micro RNA 上的 SNP 以分析 miRNA 的起源
批准号:
25670369
负责人:
CHAYAMA Kazuaki
金额:
$2.41万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Challenging Exploratory Research
财政年份:
2013
资助国家:
日本
项目状态:
已结题
起止时间:
2013-04-01 至 2014-03-31

项目摘要

项目成果

CHAYAMA Kazuaki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Recent research made it clear that there are certain amount of circulating miRNA in serum, which present in serum associated with proteins such as AGO1 and AGO2. Such AGO-protein bound miRNA is quite stable and detectable by polymerase chain reaction after extraction from the serum samples and reverse transcription. We attempted to analyze organs which secrete each miRNA by analyzing circulating miRNA that is present in serum samples. To perform this analysis we tried to identify SNPs that is present in miRNA. We searched for such SNP in entire human genome analyzing human genome database and identified several candidate SNPs. Although we attempted to detect such miRNA with digital PCR, detection of small amount of miRNA was quite difficult. Further study is needed to detect such small amount of miRNA in serum samples.
期刊论文(89)
专著(0)
科研奖励(0)
会议论文
Thromboxane A2 Synthase Inhibitors Prevent Production of Infectious Hepatitis C Virus in Mice with Humanized Livers.
血栓素 A2 合酶抑制剂可防止具有人源化肝脏的小鼠产生传染性丙型肝炎病毒。
DOI: 10.1053/j.gastro.2013.05.014
发表时间: 2013
期刊: Gastroenterology
影响因子: 29.4
作者: [Abe Y, Aly HH, Hiraga N, Imamura M, Wakita T, Shimotohno K, Chavama K, Hijikata M.]
通讯作者: Hijikata M.
New Treatment Paradigms for HCV: The Basics
HCV 新治疗模式:基础知识
DOI: --
发表时间: 2014
期刊:
影响因子: --
作者: [Chayama K , Hayes CN, Ohishi W,Kawakami Y, 茶山一彰, 茶山一彰, 茶山一彰]
通讯作者: 茶山一彰
Treatment of Chronic Hepatitis C with First Generation Protease Inhibitors in Asian Population:Telaprevir-Based Triple Therapy in Japanese Population
第一代蛋白酶抑制剂治疗亚洲人群慢性丙型肝炎:日本人群基于特拉匹韦的三联疗法
DOI: --
发表时间: 2013
期刊:
影响因子: --
作者: [Chayama K , Hayes CN, Ohishi W,Kawakami Y, 茶山一彰, 茶山一彰, 茶山一彰, 茶山一彰, 茶山一彰, 茶山一彰, 茶山一彰, 茶山一彰, 茶山一彰, 茶山一彰, 茶山一彰, 茶山一彰, 茶山一彰, 茶山一彰, 茶山一彰, 茶山一彰, 茶山一彰]
通讯作者: 茶山一彰
DAAs時代におけるC型慢性肝炎治療戦略と今後の展望
DAA时代慢性丙型肝炎治疗策略及未来展望
DOI: --
发表时间: 2013
期刊:
影响因子: --
作者: [Chayama K , Hayes CN, Ohishi W,Kawakami Y, 茶山一彰, 茶山一彰, 茶山一彰, 茶山一彰, 茶山一彰, 茶山一彰, 茶山一彰, 茶山一彰, 茶山一彰, 茶山一彰, 茶山一彰, 茶山一彰, 茶山一彰, 茶山一彰, 茶山一彰, 茶山一彰, 茶山一彰, 茶山一彰, 茶山一彰]
通讯作者: 茶山一彰
66
    Analysis of unknown pathogen using human hepatocyte chimeric mouseand massive parallel sequencing
    • 批准号:
      24659368
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2012
    • 负责人:
      CHAYAMA Kazuaki
    • 依托单位:
    Generation of a mouse model that shows specific features of human diseases.
    • 批准号:
      22659147
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.07万
    • 财政年份:
      2010
    • 负责人:
      CHAYAMA Kazuaki
    • 依托单位:
    A comprehensive transcriptome analysis of humanized mouse liver using ultra high density cDNA micro array
    • 批准号:
      21390229
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.73万
    • 财政年份:
      2009
    • 负责人:
      CHAYAMA Kazuaki
    • 依托单位:
    Production of interferon stimulated gene library and screening of new therapeutic drug for hepatitis viruses
    • 批准号:
      18390218
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.35万
    • 财政年份:
      2006
    • 负责人:
      CHAYAMA Kazuaki
    • 依托单位:
    国内基金
    海外基金
    RBM38基因SNP对人红细胞卟啉代谢的影响
    • 批准号:
      2025JJ81130
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      刘康
    • 依托单位:
    风险SNP介导的增强子通过FAM13A在哮喘 肺泡巨噬细胞中引发M1型炎症的机制研 究
    FST基因调控猪乳腺原基上皮细胞功能研究及其因果SNP位点鉴定
    • 批准号:
      2025JJ60129
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      刘晨曦
    • 依托单位:
    图表示学习的SNP模型研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      郭平
    • 依托单位: